[ad_1]
Jinxi Falls, QC, July 5, 2021 /PRNewswire/-Cascades Inc. (Toronto Stock Exchange:case) (The “Company”) is pleased to announce that it has partnered with Apollo Global Management, Inc. (NYSE:Apolipoprotein) (Together with its consolidated subsidiary “Apollo”) sold its 57.6% equity in Reno De Medici SpA (BIT: RM) (“Reno de Medici” or “RDM”) net cash per share at a full cash price of 1.45 Euros The consideration is approximately 315.3 million euros (approximately 461 million Canadian dollars). Unless the 2020 dividends paid by RDM to shareholders in 2020 may reveal value to the seller, the purchase price cannot be adjusted. May 2021 It will not be considered a leak.
The selling price is 24% premium to RDM’s 90-day volume-weighted moving average share price, which is 6.9 times RDM’s adjusted operating income for the past 12 months ending before depreciation March 31, 2021After the recently announced completion of the acquisition of Eska Group, RDM…
The full story on Benzinga.com
[ad_2]
Source link
